GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » Inventories, Inventories Adjustments

Statera BioPharma (STU:7CB) Inventories, Inventories Adjustments : €0.00 Mil (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma Inventories, Inventories Adjustments?

Statera BioPharma's Inventories, Inventories Adjustments for the quarter that ended in Sep. 2022 was €0.00 Mil.


Statera BioPharma Inventories, Inventories Adjustments Historical Data

The historical data trend for Statera BioPharma's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma Inventories, Inventories Adjustments Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
Inventories, Inventories Adjustments
- - -

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Inventories, Inventories Adjustments Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Statera BioPharma Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.


Statera BioPharma (STU:7CB) Business Description

Industry
Traded in Other Exchanges
N/A
Address
4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma (STU:7CB) Headlines

No Headlines